Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?

OBJECTIVE: To compare discontinuation rates of first and second biologics in rheumatoid arthritis (RA) by tumour-necrosis factor inhibitor (TNFi) status and identify predictors and reasons for discontinuation. METHODS: From 1998 to 2011, self-reported medication use for RA was assessed every 6 month...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:RMD Open
Main Authors: Ramiro, Sofia, Landewé, Robert, van der Heijde, Désirée, Harrison, David, Collier, David, Michaud, Kaleb
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2015
Assuntos:
Rheumatoid Arthritis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4654098/
https://ncbi.nlm.nih.gov/pubmed/26629366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2015-000155
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares